First line of the email MUST contain NCT # and Site #.
CONTACT
Lead
Celgene
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Received at least one gene-modified (GM) T-cell infusion in a previous Celgene sponsored, Juno Therapeutics, other affiliates of BMS, or Celgene alliance partner-sponsored trial, and have discontinued, or completed the post-treatment follow-up period in the parent treatment protocol, as applicable.
Must understand and voluntarily sign an Informed Consent Form/Informed Assent Form prior to any study-related assessments/procedures being conducted.
You may not be if
Not Applicable
Clareo Health | Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
